Regmi, N., Abar, B., Lim, J.-A., Kenney-Jung, D., Malinzak, M., Hagarty-Waite, K. A., … Kishnani, P. S. (2026). Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease. EBioMedicine, 123, 106096–106096. https://doi.org/10.1016/j.ebiom.2025.106096

Regmi, Neha, Bijan Abar, Jeong-A Lim, Daniel Kenney-Jung, Michael Malinzak, Kristen A. Hagarty-Waite, Karra A. Jones, et al. “Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease.” EBioMedicine 123 (January 2026): 106096–106096. https://doi.org/10.1016/j.ebiom.2025.106096.

Regmi N, Abar B, Lim J-A, Kenney-Jung D, Malinzak M, Hagarty-Waite KA, et al. Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease. eBioMedicine. 2026 Jan;123:106096–106096.

Regmi, Neha, et al. “Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease.” EBioMedicine, vol. 123, Elsevier BV, Jan. 2026, pp. 106096–106096. Crossref, doi:10.1016/j.ebiom.2025.106096.

Regmi N, Abar B, Lim J-A, Kenney-Jung D, Malinzak M, Hagarty-Waite KA, Jones KA, Jung S-H, Stiles AR, Koch RL, Kishnani PS. Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease. eBioMedicine. Elsevier BV; 2026 Jan;123:106096–106096.